The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion

被引:148
作者
Sharp, AM
Stein, PE
Pannu, NS
Carrell, RW
Berkenpas, MB
Ginsburg, D
Lawrence, DA
Read, RJ
机构
[1] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada
[2] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada
[3] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England
[4] Pharmacia & Upjohn Inc, Kalamazoo, MI 49007 USA
[5] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[6] Amer Red Cross, Jerome H Holland Lab, Dept Biochem, Rockville, MD 20855 USA
基金
英国惠康基金;
关键词
metastable state; plasminogen activator inhibitor 1; serpin; structure-based drug design;
D O I
10.1016/S0969-2126(99)80018-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Plasminogen activator inhibitor 1 (PAI-1) is a serpin that has a key role in the control of fibrinolysis through proteinase inhibition. PAI-1 also has a role in regulating cell adhesion processes relevant to tissue remodeling and metastasis; this role is mediated by its binding to the adhesive glycoprotein vitronectin rather than by proteinase inhibition. Active PAI-1 is metastable and spontaneously transforms to an inactive latent conformation. Previous attempts to crystallize the active conformation of PAI-1 have failed. Results: The crystal structure of a stable quadruple mutant of PAI-1(Asn150-->His, Lys154-->Thr, Gln319-->Leu, Met354-->Ile) in its active conformation has been solved at a nominal 3 Angstrom resolution. In two of four independent molecules within the crystal, the flexible reactive center loop is unconstrained by crystal-packing contacts and is disordered. In the other two molecules, the reactive center loop forms intimate loop-sheet interactions with neighboring molecules, generating an infinite chain within the crystal. The overall conformation resembles that seen for other active inhibitory serpins. Conclusions: The structure clarifies the molecular basis of the stabilizing mutations and the reduced affinity of PAI-1, on cleavage or in the latent form, for vitronectin. The infinite chain of linked molecules also suggests a new mechanism for the serpin polymerization associated with certain diseases. The results support the concept that the reactive center loop of an active serpin is flexible and has no defined conformation in the absence of intermolecular contacts. The determination of the structure of the active form constitutes an essential step for the rational design of PAI-1 inhibitors.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 42 条
[1]   MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, CJ ;
DECLERCK, PJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :891-897
[2]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[3]   Antithrombins Wibble and Wobble (T85M/K): Archetypal conformational diseases with in vivo latent - Transition, thrombosis, and heparin activation [J].
Beauchamp, NJ ;
Pike, RN ;
Daly, M ;
Butler, L ;
Makris, M ;
Dafforn, TR ;
Zhou, A ;
Fitton, HL ;
Preston, FE ;
Peake, IR ;
Carrell, RW .
BLOOD, 1998, 92 (08) :2696-2706
[4]  
Bell William R., 1996, Seminars in Thrombosis and Hemostasis, V22, P459
[5]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[6]   Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis [J].
Björquist, P ;
Ehnebom, J ;
Inghardt, T ;
Hansson, L ;
Lindberg, M ;
Linschoten, M ;
Strömqvist, M ;
Deinum, J .
BIOCHEMISTRY, 1998, 37 (05) :1227-1234
[7]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[8]  
Brunger AT., 1993, X PLOR VERSION 3 1 S
[9]   MOBILE REACTIVE CENTER OF SERPINS AND THE CONTROL OF THROMBOSIS [J].
CARRELL, RW ;
EVANS, DL ;
STEIN, PE .
NATURE, 1991, 353 (6344) :576-578
[10]   BIOLOGICAL IMPLICATIONS OF A 3-ANGSTROM STRUCTURE OF DIMERIC ANTITHROMBIN [J].
CARRELL, RW ;
STEIN, PE ;
WARDELL, MR ;
FERMI, G .
STRUCTURE, 1994, 2 (04) :257-270